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Abstract: Starting from an enantiopure 3-amino-substituted
pyran derivative, the synthesis of a series of divalent 1,2,3-tri-
azole-linked carbohydrate mimetics is described. The prepara-
tion of the required 3-azido-substituted pyran proceeds
smoothly by copper-catalyzed diazo transfer. Using different
conditions for the Huisgen-Meldal-Sharpless cycloaddition, this
azide reacts with several diynes to furnish the desired divalent
carbohydrate mimetics bearing rigid or flexible linker units. The
in situ generation of the 3-azidopyran in the presence of Cu/C
as catalyst followed by the reaction with the alkyne allows a
direct one-pot transformation from the 3-aminopyran to the
Introduction
Synthetic C-glycosides and other carbohydrate mimetics are
compounds of great interest due to their similarity to carbo-
hydrate structures.[1,2] Their modified properties may influence
bioavailability, selectivity, and affinity in important biological
processes involving carbohydrates. Our group discovered an
alkoxyallene-based[3] straightforward access to enantiopure 3-
aminopyrans of general structure A and the closely related ring-
expanded 4-aminooxepanes (Scheme 1).[4] Among compounds
A, the 6,6-dimethyl-substituted 3-aminopyran 1 is the most eas-
ily available derivative[4a,4b] and hence its properties were inves-
tigated in detail.[4e,4f ] Most remarkably, the connection of 1 to
gold nanoparticles via amide bonds and subsequent O-sulf-
ation of the pyran hydroxyl groups provided a multivalent
macromolecular species that turned out to be a highly potent
inhibitor of L- and P-selectin with IC50 values in the picomolar
range.[5] L- and P-selectins are crucial components in the inflam-
matory process[6] and therefore compounds inhibiting their ac-
tivity are of interest as potential therapeutics.[7] The mentioned
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desired click products. We also examined the Sakai-Westermann
method that transfers primary amines with the aid of α,α-di-
chlorotosylhydrazones into 1,2,3-triazoles. These copper-free
click conditions were applied for the first time to the prepara-
tion of a divalent compound. The O-sulfation of the carbo-
hydrate mimetics was achieved using the SO3-DMF complex
under careful 1H-NMR control. Five polysulfated compounds
could be obtained in pure form and these were tested by sur-
face plasmon resonance spectroscopy as inhibitors of L-selectin
giving IC50 values between 45 nM and 50 μM.
aminopyran-decorated gold nanoparticles are densely packed
with 1000–1200 ligands. For an understanding of the activity of
these multivalent species, we studied analogous compounds
that contain only a few of the aminopyrans ligands. Therefore
we synthesized divalent and trivalent compounds of general
structure B employing metal-catalyzed reactions (Scheme 1).[8]
We also connected two or three aminopyrans units 1 via amide
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bonds to compounds of general structure C with rigid or flexi-
ble linker units.[9] Similar compounds could be prepared by re-
ductive amination.[10]
In this report, we employ enantiopure 3-azido-substituted
pyran 2 to synthesize the related divalent products D that are
connected via 1,2,3-triazole units. The well-established Huisgen-
Meldal-Sharpless copper-catalyzed azide-alkyne cycloaddition
(click reaction)[11,12] has already been successfully used by our
group for the reactions of the analogous 4-azidooxepanes.[13]
Alternatively, the so-far under-explored Sakai-Westermann
method[14,15] was examined to convert 3-aminopyran 1 into D.
The resulting divalent pyran derivatives D were subsequently O-
sulfated and investigated by surface plasmon resonance (SPR)
spectroscopy as L-selectin inhibitors.
Results and Discussion
The conversion of 3-aminopyran 1 into the required azido-sub-
stituted pyran 2 was achieved by a copper sulfate-catalyzed
diazo transfer that has previously been established as very ef-
fective and easy to perform route to organic azides.[16] In our
group, the use of nonafluorobutanesulfonyl azide (NfN3)[17] was
implemented as a safe alternative to the commonly used tri-
fluoromethanesulfonyl azide (TfN3).[18] NFN3 is less explosive
and volatile than TfN3 and therefore its handling is much easier
and highly recommendable.[19] The copper sulfate-catalyzed re-
action of 1 with NfN3 smoothly furnished the fully deprotected
3-azidopyran 2 in excellent yield and under retention of config-
uration at C-3 (Scheme 2).
Scheme 2. Conversion of 3-aminopyran 1 into 3-azido-substituted pyran 2 by
copper sulfate-catalyzed diazo transfer employing nonafluorobutanesulfonyl
azide.
Different reaction conditions were examined for the copper-
catalyzed azide-alkyne cycloadditions (CuAAC) of 3-azidopyran
2 with simple terminal alkynes 3 and 4 (Scheme 3). In these
model reactions, we applied methods previously employed in
our group using either CuI and tris-[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]-amine (TBTA) as ligand (method A)[4b,13] or an acid/
base-catalyzed modification (method B) adapting a recently re-
ported procedure.[20] We were also interested in exploring the
efficiency of Cu/C, an inexpensive heterogeneous catalyst for
CuAAC reactions (method C).[21] One of the advantages of this
method is the fact that the cycloadditions occur in the Cu/C
matrix, thus avoiding the presence of copper in solution and
preventing contamination of the final products with the metal.
Additional advantages are the easy removal of the catalyst by
simple filtration through a pad of Celite® and its reusability. On
the other hand, this method required a reaction temperature
of 60 °C whereas methods A and B were applied at room tem-
perature.
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Scheme 3. Model CuAAC of 3-azidopyran 2 with alkynes 3 and 4 leading to
1,2,3-triazoles 5 and 6. Method A: CuI, TBTA, NEt3, MeCN, 20 h, r.t.; method
B: CuI, N(iPr)2Et, HOAc, toluene, 20 h, r.t.; method C: Cu/C, NEt3, 1,4-dioxane,
20 h (for 5) 21 h (for 6), 60 °C.
The cycloaddition of 2 and 3 proceeded smoothly with
methods A and C providing 1,4-disubstituted 1,2,3-triazole de-
rivative 5 in excellent yields, but the purification of the product
obtained by method A is not as straightforward due to the
presence of the fairly large amounts of the TBTA ligand. Employ-
ing the acid/base-catalyzed method B the desired product 5
was obtained with a lower yield of 67 %. Due to the relatively
high polarity of 1,2,3-triazole 5 an extraction was not possible
and separation of the product from the acid and base was less
efficient. For the synthesis of 1,2,3-triazole derivative 6 from
alkyne 4 only method C was examined that furnished the de-
sired product quantitatively.
Since we planned to test the prepared carbohydrate mimet-
ics in biological assays, it should be assured that no copper is
present in the obtained compounds. The three samples of 1,2,3-
triazole derivative 5 obtained by the alternative CuAAC meth-
ods A, B, and C depicted in Scheme 3 were submitted to quanti-
tative copper ICP-MS analyses. Values in the range between
4–8 ppb for 63Cu and 65Cu were obtained; these are lower than
15 ppb which is regarded as the sensitivity limit of this method.
For the synthesis of divalent structures diynes 7 and 8 with
rigid arene centers and diynes 9 and 10 with flexible aliphatic
linker units were chosen (Scheme 4). Alkynes 7, 8, and 9 and 3-
azidopyran 2 were subjected to method A using CuI and TBTA.
Although all desired divalent bis-1,2,3-triazoles 11–14 were ob-
tained in good yields, the reactions of alkynes 8 and 9 also
provided small amounts of the corresponding mono-1,2,3-tri-
azoles.
The acid/base-catalyzed CuAAC (method B) was examined
with diyne 9. Using toluene as solvent and a mixture of Hünig
base/acetic acid led to a fast reaction and a slight improvement
of the yield. Apparently, the use of TBTA as additive is not nec-
essary, whose removal is sometimes tedious.[13] Due to the ex-
cellent results observed with Cu/C-catalyzed CuAAC (method
C) for the synthesis of the model 1,2,3-triazoles and the easy
purification of the obtained compounds, these conditions were
also applied to the synthesis of divalent compound 14. The
commercially available diyne 10 and 3-azidopyran 2 furnished
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Scheme 4. Synthesis of bis-1,2,3-triazoles 11–14 by CuAAC of 3-azidopyran 2
with diynes 7–10. Method A: CuI, TBTA, NEt3, MeCN, r.t.; method B: CuI,
N(iPr)2Et, HOAc, toluene, r.t.; method C: Cu/C, NEt3, 1,4-dioxane, 60 °C.
In our study on 4-aminooxepanes we also prepared a bis-
(azido)oxepane derivative that underwent a twofold CuAAC
with an excess of 1,6-heptadiyne affording an unsymmetrical
diyne 15 (Scheme 5).[13] In order to enhance the degree of com-
plexity, compound 15 was treated with 3-azido-substituted
pyran 2 employing the approved method C. The reaction pro-
ceeded smoothly, but product 16 with three carbohydrate
mimicking subunits and four connecting 1,2,3-triazole moieties
was extremely polar and hence hard to purify, resulting in a
disappointingly low yield of 24 %.
The Cu/C matrix contains copper(I) as well as copper(II) spe-
cies and therefore the Lipshutz group explored the direct one-
pot transformation of amines into the desired 1,2,3-triazoles by
in situ generation of the corresponding organic azides employ-
ing TfN3.[22] We tested these reported one-pot conditions for
the synthesis of the desired carbohydrate mimetics. It should
be possible to start from 3-aminopyran 1 and after in situ gen-
eration of the 3-azidopyran 2, an alkyne can be added and the
desired cycloaddition product should be obtained. Lipshutz et
al. reported that the method proceeds in dichloromethane as
solvent,[22] but we found for our compounds that under these
conditions only unchanged 3-aminopyran 1 and 3-azidopyran
2 and no 1,2,3-triazoles were isolated. An optimization revealed
that acetonitrile was a suitable solvent and we could success-
fully apply the one-pot procedure to the syntheses of 1,2,3-
triazole 5 and bis-1,2,3-triazole 14 (Scheme 6). For the prepara-
tion of the simple 1,2,3-triazole 5 we used the convenient and
safe NfN3 as reagent (method D) and the product was isolated
in satisfying 75 % yield. The divalent product 14 was prepared
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Scheme 5. Synthesis of unsymmetrical tetrakis-1,2,3-triazole 16 by CuAAC of
diyne 15 and 3-azidopyran 2. Method C: Cu/C, NEt3, 1,4-dioxane, 72 h, 60 °C.
with TfN3 as a reagent for the diazo transfer (method E) and
the yield was only 38 %; no control experiment with NfN3 was
performed to identify the reason for the lower efficiency in this
example. In any case, the two experiments depicted in
Scheme 6 indicate that the one-pot procedure for the diazo
transfer and CuAAC may be a good alternative to the step-wise
route.[23]
Scheme 6. One-pot syntheses of 1,2,3-triazole 5 and of divalent bis-1,2,3-
triazole 14 starting from amine 1 using a Cu/C-catalyzed one-pot procedure.
Method D: a) Cu/C, Ba(OH)2, NfN3, MeCN, 15 h, r.t.; b) addition of alkyne 3,
NEt3, 2 d, 60 °C; method E: a) Cu/C, Ba(OH)2, TfN3, MeCN, 1 h, r.t.; b) addition
of diyne 10, NEt3, 4 d, 60 °C.
The methods presented above proved to be very suitable for
the (3+2) cycloaddition leading to the desired 1,2,3-triazoles,
however, they all require copper as metal catalyst. Orthogonal
ligation protocols have been widely used as an alternative for
the common CuAAC.[24] A so far less explored possibility for the
regioselective preparation of 1,4-disubstituted triazoles em-
ploys the Sakai reaction of primary amines with α,α-dichloro-
tosylhydrazones.[14] In 2012, Westermann et al. reinvestigated
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and the modification of biologically significant target com-
pounds.[15] The impressive results prompted us to briefly study
the potential of this copper-free alternative for the construction
of carbohydrate mimetics starting directly from 3-aminopyran
1. For the first trial the simple α,α-dichlorotosylhydrazones 17
and 19 were chosen (Scheme 7).[15] Following Westermann's
protocol for the Sakai reaction the simple 1,2,3-triazoles 18 and
20 were obtained in excellent or good yield. To further evaluate
the efficacy of this procedure, the synthesis of a divalent carbo-
hydrate mimetic was also attempted. For this purpose, the
bis(α,α-dichlorotosylhydrazone) 21 was prepared in two steps
starting from dimethyl adipate and dichloromethane.[25] The
metal-free connection of this compound with 3-aminopyran 1
furnished the bis-1,2,3-triazole 22 in good yield. To the best of
our knowledge, this transformation is the first application of
the Sakai-Westermann method for the synthesis of a divalent
compound. With easily obtained and bench stable starting ma-
terials this method proved to be a good alternative for the
metal-free direct conversion of primary amines into compounds
with 1,2,3-triazole units without the need to generate poten-
tially hazardous azide intermediates.
Scheme 7. Synthesis of 1,2,3-triazoles 18, 20 and 22 using the Sakai-Wester-
mann method. Method F: KOAc, EtOH, MeCN, 21 h (for 18), 26 h (for 20),
20 h (for 22), 0 °C to r.t.
For the evaluation as selectin ligands the prepared oligo-
hydroxylated compounds had to be converted into the corre-
sponding O-sulfated samples which is not a trivial challenge.[26]
We recently reported optimizations of the O-sulfation step of
multivalent carbohydrate mimetics connected with amide
bonds and the commercially available sulfur trioxide-DMF com-
plex was found to be the reagent of choice.[9] It was employed
in (deuterated) DMF, thus allowing to follow the reaction
progress with high-resolution 1H-NMR spectroscopy. Here we
present the successful application of this method for the
O-sulfation of 3-azidopyran 2 and multivalent carbohydrate
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mimetics bearing 1,2,3-triazole units (Scheme 8). After O-sulf-
ation all sulfuric acid monoesters were converted into the corre-
sponding sodium salts using either a 1 M solution of sodium
hydroxide (method G/a) or 0.5 M solution of this base (method
G/b). The resulting products were finally purified by dialysis. 3-
Azidopyran 2 and 1,2,3-triazole 18 were successfully converted
into the desired products 23 and 24 (Scheme 8). Only low yields
were observed for the two simple compounds due to their low
molecular mass that leads to considerable losses of mass during
the dialysis purification. Higher yields were observed for the
O-sulfated divalent compounds 25–27. In agreement with our
previous results, method G/b is favorable for the compounds
with 1,2,3-triazole substructures. The two divalent compounds
11 and 12 (Scheme 4) with rigid arene linker units were also
treated under the approved conditions with the sulfur trioxide-
DMF complex and they were completely consumed, but after
dialysis high-resolution 1H-NMR spectroscopy revealed that
complex mixtures of compounds were formed. To our regret,
Scheme 8. O-Sulfation of 3-azidopyran 2, 1,2,3-triazole 18 and divalent com-
pounds 13, 22, and 14 leading to the corresponding O-sulfated carbohydrate
mimetics 23–27. Method G/a: 1) SO3-DMF, [D7]DMF, 2 d (for 2), 1 d (for 13),
1 d (for 14), r.t.; 2) 1 M NaOH, 0 °C; 3) dialysis, H2O; method G/b: 1) SO3·DMF,
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these interesting compounds could therefore not be investi-
gated further by SPR experiments.
The five O-sulfated samples obtained were investigated by
surface plasmon resonance (SPR) spectroscopy and as earlier
found for this type of compounds a competitive binding assay
was applied.[27] The resulting IC50 values for binding to
L-Selectin are compiled in Figure 1 and should be regarded as
preliminary results that need further validation. For the mono-
valent O-sulfated 3-azidopyran 23 the lowest IC50 value of
45 nM was found, however, this result has to be regarded with
caution since the dose-response curve ascended slightly at
higher concentrations. For the four 1,2,3-triazole derivatives 24–
27 IC50 values in the range of 0.6–50 μM were determined. The
most potent compound 25 is characterized by the smallest dis-
tance between the two O-sulfated pyran moieties. The low
number of comparable compounds does not allow a sound in-
terpretation of their observed inhibitor properties. At the mo-
ment it is pure speculation that fairly close O-sulfated pyran
moieties as in the divalent compound 25 (and in the multi-
valent polysulfated pyran-decorated gold nanoparticles men-
tioned in the introduction) are a prerequisite for high activity
of these compounds.
Figure 1. IC50 values for L-selectin of O-sulfated compounds 23–27 deter-
mined by surface plasmon resonance spectroscopy (* this value needs re-
evaluation since the dose-response curve ascended again at higher concen-
trations).
Conclusions
A series of divalent carbohydrate mimetics 11–14 linked by
1,2,3-triazole moieties was prepared by starting with 3-azido-
pyran derivative 2. The Huisgen-Meldal-Sharpless (3+2) cyclo-
additions with alkynes proved to be generally applicable and
very good results were found in particular with Cu/C as cata-
lyst.[28] A one-pot method that allowed direct conversion of
3-aminopyran 1 into 1,2,3-triazoles was also successfully exam-
ined. We found that the copper-free Sakai-Westermann protocol
allows the efficient transformation of primary amines such as 1
into 1,2,3-triazoles including the divalent carbohydrate mimetic
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22. After O-sulfation of the compounds with the sulfur trioxide-
DMF complex five products were isolated in sufficient purity.
They were investigated by SPR as inhibitors of L-selectin and
IC50 values between 45 nM and 50 μM were found. These prelim-
inary results need further confirmation and inclusion of more
compounds in order to prove or disprove a multivalency ef-
fect.[29] In summary, the presented synthetic results show that
the azide-alkyne (3+2) cycloadditions and the related methods
furnish carbohydrate mimetics with interesting structural fea-
tures.
Experimental Section
Reactions were generally performed under an inert atmosphere
(argon) in flame-dried flasks. Solvents and reagents were added by
syringe. Solvents were dried using standard procedures and were
purified with a MB SPS-800-dry solvent system. Triethylamine was
distilled from CaH2 and stored with KOH under an argon atmos-
phere. Commercially available reagents were used as received with-
out further purification unless otherwise stated. Products were puri-
fied by flash chromatography on silica gel (230–400 mesh, Merck
or MACHEREY-NAGEL) or by ion exchange resin (DOWEX® 50WX8–
200 Sigma-Aldrich). DOWEX® Na+ was freshly prepared by washing
DOWEX® with a saturated solution of NaCl. Unless stated otherwise,
yields refer to analytical pure samples. TLC analyses were performed
on silica gel coated aluminum plates (Merck). Products were de-
tected by UV and by using staining reagents (cerium/molybdenum
reagent, KMnO4, and ninhydrin).
NMR spectra were recorded with BRUKER (AV 500, AV 700) and JEOL
(ECP 500) instruments. Chemical shifts (δ) are listed in parts per
million (ppm) and are reported relative to solvent residual signals:
CD3OD (1H: δ = 3.31 ppm, 13C: δ = 49.0 ppm), [D7]DMF (1H: δ =
2.75 ppm, 13C: δ = 29.8 ppm) or D2O (1H: δ = 4.79 ppm). Integrals
are in accordance with assignments; coupling constants J are given
in Hz. All 13C-NMR spectra are proton-decoupled. Multiplicity is indi-
cated as follows: s (singlet), sb (broad singlet), d (doublet), t (triplet),
q (quartet), quint (quintet), dd (doublet of doublet), dt (doublet of
triplet), td (triplet of doublet), m (multiplet), mc (centered multiplet).
For detailed peak assignments 2D spectra were measured (COSY
and HMQC). IR spectra were measured with a JASCO spectrometer
(FT/IR-4100 with DLATGS Detector). HRMS analyses were performed
with Agilent 6210 (ESI-TOF, 10 μL/min, 1.0 bar, 4 kV) and Varian/
Agilent Ionspec QFT-7 (ESI-FTICR, 4 μL/min, 1.0 bar, 4 kV) instru-
ments. Elemental analyses were carried out with PerkinElmer (CHN-
Analyzer 2400) and Elementar (Vario, Vario EL, Vario EL III) instru-
ments. Melting points were measured with a Reichert apparatus
(Thermovar) and are uncorrected.
General Procedure (GP1), CuAAC using TBTA (Method A): 3-Azido-
pyran 2 (1.0 equiv.) was dissolved in MeCN (40 mL/mmol). Tris-[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (0.23 equiv.) and
CuI (0.23 equiv.) were added, followed by the addition of the corre-
sponding alkyne (1.2 equiv.) and NEt3 (0.23 equiv.). The resulting
mixture was stirred at r.t. for the indicated time. The solution was
quenched with 7 N NH3 in MeOH and the resulting mixture was
filtered through a short silica gel column and washed with a mix-
ture of CH2Cl2/7 N NH3 in MeOH (10:1). After removing the solvents
in vacuo, the crude product was purified by flash column chroma-
tography.
General Procedure (GP2), CuAAC using DIPEA/AcOH (Method
B): To a suspension of 3-azidopyran 2 (1.0 equiv.) in toluene (1 mL/
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(1.2 equiv.) and finally diisopropylethylamine (DIPEA) (4.0 equiv.)
and HOAc (4.0 equiv.). The reaction mixture was stirred at r.t. during
the indicated time. The solution was quenched with 7 N NH3 in
MeOH and the resulting mixture was filtered through a short silica
gel column and washed with a mixture of CH2Cl2/7 N NH3 in MeOH
(10:1). After removing the solvents in vacuo, the crude product was
purified by flash column chromatography.
General Procedure (GP3), CuAAC using Cu/C (Method C): To a
solution of 3-azidopyran 2 (1.0 equiv.) in 1,4-dioxane (3 mL/mmol)
were added Cu/C (0.1–0.5 equiv.), NEt3 (1.2–3.0 equiv.) and the cor-
responding alkyne (1.2 equiv.). The reaction mixture was stirred at
60 °C during the indicated time. The mixture was filtered through
a pad of Celite® and washed with MeOH. When indicated, the prod-
uct was further purified by flash column chromatography.
General Procedure (GP4), One-pot click reaction using Cu/C
(Methods D and E): 3-Aminopyran 1 (1.0 equiv.), Cu/C (0.1 equiv.)
and Ba(OH)2 (1.0 equiv.) were dissolved in MeCN (1 mL/mmol). TfN3
or NfN3 was added dropwise at r.t. under constant stirring. After
the diazo transfer was complete (controlled by TLC, CH2Cl2/MeOH,
9:1), Cu/C (0.1 equiv.), NEt3 (5.0 equiv.) and the corresponding alk-
yne were added and the reaction mixture was stirred at 60 °C. After
the total consumption of TfN3 or NfN3 (controlled by TLC, CH2Cl2/
MeOH, 9:1) the mixture was filtered through a pad of Celite® and
washed with MeOH. The product was purified by flash column chro-
matography.
General Procedure (GP5), Metal free triazole synthesis using
tosylhydrazones (Method F): To a cooled solution of 3-amino-
pyran 1 (1.0 equiv.) in EtOH (12 mL/mmol), KOAc (3.0 equiv.) was
added and the resulting solution was stirred for 10 min at 0 °C. The
corresponding α,α-dichlorotosylhydrazone (1.3 equiv.) was dis-
solved in MeCN (6 mL/mmol) and added dropwise to the reaction
mixture. Stirring was continued at r.t. until the reaction was com-
plete (monitored by TLC). All volatiles were removed in vacuo and
the crude product was purified by flash column chromatography.
General Procedure (GP6), O-sulfation (Method G): The corre-
sponding polyol (1.0 equiv.) was dissolved in [D7]DMF (0.6–1.0 mL).
The solution was cooled to 0 °C and SO3-DMF (3.0 equiv. per OH)
was added. The reaction mixture was stirred at r.t. during the indi-
cated time. The reaction progress was followed by 1H-NMR spectro-
scopy (700 MHz). When indicated, additional SO3-DMF (1.0–
3.0 equiv. for each OH group) was added and the reaction mixture
was stirred at r.t. for the additional time given until full conversion
was observed. The obtained sulfated intermediates were directly
converted into the corresponding sodium salts either by method
G/a or method G/b.
Method G/a: The reaction mixture was cooled to 0 °C and an aq.
1 M solution of NaOH was added dropwise until pH 10–12 was
reached. The solvents were removed in vacuo and the crude prod-
uct was purified by dialysis in H2O.
Method G/b: The reaction mixture was cooled to 0 °C and an aq.
0.5 M solution of NaOH was added dropwise until pH 7–9 was
reached. The reaction mixture was filtered through an ion exchange
DOWEX® Na+ column. The solvents were removed in vacuo and the
crude product was purified by dialysis in H2O.
The final products were filtered through a syringe filter (diameter
25 mm; pore size 0.2 μm; PTFE membrane) when indicated.
(2S,3R,4S,5S)-(3-Azido-4-hydroxy-6,6-dimethyltetrahydro-2H-
pyran-2,5-diyl)dimethanol (2): To a solution of 3-aminopyran 1[4b]
(150 mg, 0.73 mmol) in MeOH/H2O (2:1, 3 mL) at r.t. were added
CuSO4·5H2O (18 mg, 0.073 mmol) and K2CO3 (101 mg, 0.73 mmol),
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followed by slow addition of freshly prepared NfN3[17] (475 mg,
1.46 mmol). The mixture was stirred for 24 h, then glycine hydro-
chloride (554 mg, 5.00 mmol) was added and the suspension was
stirred for another 24 h. The solution was quenched with 7 N NH3
in MeOH and the copper salt was filtered off through a short silica
gel column. The crude product was purified by flash column chro-
matography (silica gel, CH2Cl2 100 %, CH2Cl2/MeOH, 95:5 then
90:10) affording 2 (301 mg, 89 %) as a colorless solid. M. p. 121 °C;
[α]D22 = –18.4 (c = 0.76, MeOH); 1H NMR (500 MHz, CD3OD): δ = 1.14,
1.34 (2 s, 3 H each, Me), 1.82 (td, J ≈ 6.0, 9.3 Hz, 1 H, 5-H), 3.51 (dd,
J = 4.1, 5.5 Hz, 1 H, 3-H), 3.56, 3.63 (AB part of ABX system, JAB =
11.2 Hz, JAX = 5.7 Hz, JBX = 7.0 Hz, 1 H each, 2-CH2), 3.68, 3.80 (AB
part of AB system, JAB = 11.1 Hz, JAX = 5.6 Hz, JBX = 6.6 Hz, 1 H
each, 5-CH2), 3.92 (dd, J = 5.5, 9.3 Hz, 1 H, 4-H), 4.02 (ddd, J = 4.1,
5.7, 7.0 Hz, 1 H, 2-H) ppm; 13C NMR (125 MHz, CD3OD): δ = 24.8,
27.0 (2 q, Me), 49.5 (d, C-5), 62.1, 62.7 (2 t, 2-CH2, 5-CH2), 68.2 (d,
C-3), 71.3 (d, C-2), 72.3 (d, C-4), 76.4 (s, C-6) ppm; IR (ATR): ν˜ = 3370
(OH), 2970–2930 (C-H), 2110 (N3), 1235 (C-O), 1045 (C-O-C) cm–1;
HRMS (ESI-TOF): m/z [M + Na]+ calcd. for C9H17N3NaO4: 254.1113,
found 254.1122; C9H17N3O4 (231.3): calcd. C 46.74, H 7.41, N 18.17;
found C 46.80, H 7.27, N 18.21.
(2S,3R,4S,5S)-{4′-Hydroxy-3-[4′-(2-hydroxyethyl)-1′H-1′,2′,3′-tri-
azol-1′-yl]-6,6-dimethyltetrahydro-2H-pyran-2,5-diyl}dimeth-
anol (5): According to GP3, to a solution of 3-azidopyran 2 (40 mg,
0.17 mmol) in 1,4-dioxane (0.6 mL) were added Cu/C (37 mg,
17 μmol), NEt3 (70 μL, 0.52 mmol) and 3-butyn-1-ol (3) (28 mg,
31 μL, 0.40 mmol). The reaction mixture was stirred at 60 °C for
20 h. The mixture was filtered through a pad of Celite® which was
washed with MeOH. The solvents were removed in vacuo and the
crude product was purified by flash column chromatography (silica
gel, CH2Cl2/MeOH, 9:1 to 6:1) affording 5 (47 mg, 0.156 mmol, 90 %)
as a colorless solid. M. p. 156–157 °C; [α]D22 = +13.7 (c = 0.98, MeOH);
1H NMR (500 MHz, CD3OD): δ = 1.28, 1.39 (2 s, 3 H each, Me), 2.06
(td, J ≈ 6.2, 12.2 Hz, 1 H, 5-H), 2.92 (t, J = 6.6 Hz, 2 H, CH2), 2.98,
3.06 (AB part of ABX system, JAB = 11.5 Hz, JAX = 4.9 Hz, JBX = 7.5 Hz,
1 H each, 2-CH2), 3.69 (dd, J = 6.4, 11.3 Hz, 1 H, 5-CH2), 3.82 (t, J =
6.6 Hz, 2 H, CH2), 3.89 (dd, J = 6.0, 11.3 Hz, 1 H, 5-CH2), 4.24–4.30
(m, 2 H, 2-H, 4-H), 4.70 (dd, J = 5.2, 7.0 Hz, 1 H, 3-H), 7.80 (s, 1 H,
5′-H) ppm; 13C NMR (125 MHz, CD3OD): δ = 23.5, 26.7 (2 q, Me),
29.9 (t, CH2), 49.5 (d, C-5), 61.6 (t, 2-CH2), 62.1 (t, CH2), 62.3 (t,
5-CH2), 70.2 (d, C-3), 71.9 (d, C-2), 73.2 (d, C-4), 77.5 (s, C-6), 124.2
(d, C-5′), 146.0 (s, C-4′) ppm; IR (ATR): ν˜ = 3360 (OH), 3160 (=C-H),
2960–2850 (C-H), 1560, 1370, 1320 (C=C), 1060, 1030 (C-O-C) cm–1;
HRMS (ESI-TOF): m/z [M + Na]+ calcd. for C13H23N3NaO5: 324.1530;
found 324.1555; C13H23N3O5 (301.3): calcd. C 51.82, H 7.69, N 13.94;
found C 51.96, H 7.72, N 13.36.
(2S,3R,4S,5S)-3-{[4′-(3-Chloropropyl)-1′H-1′,2′,3′-triazol-1′-yl]-4-
hydroxy-6,6-dimethyltetrahydro-2H-pyran-2,5-diyl}dimethanol
(6): According to GP3, to a solution of 3-azidopyran 2 (24 mg,
0.10 mmol) in 1,4-dioxane (0.3 mL) were added Cu/C (11 mg,
5.20 μmol), NEt3 (17 μL, 0.13 mmol) and 5-chloro-1-pentyne (4)
(12.8 mg, 13 μL, 0.13 mmol). The reaction mixture was stirred at
60 °C for 21 h. The mixture was filtered through a pad of Celite®
and washed with MeOH. The solvents were removed in vacuo af-
fording 6 (35 mg, quant.) as a pale yellow oil. [α]D22 = +55.9 (c =
1.32, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.29, 1.39 (2 s, 3 H
each, Me), 2.06 (td, J ≈ 6.2, 12.2 Hz, 1 H, 5-H), 2.10–2.17 (m, 2 H,
CH2), 2.86–2.91 (m, 2 H, CH2), 2.96, 3.04 (AB part of ABX system,
JAB = 11.5 Hz, JAX = 4.5 Hz, JBX = 7.5 Hz, 1 H each, 2-CH2), 3.60 (t,
J = 6.5 Hz, 2 H, CH2), 3.69 (dd, J = 6.3, 11.3 Hz, 1 H, 5-CH2), 3.89
(dd, J = 6.1, 11.3 Hz, 1 H, 5-CH2), 4.24–4.31 (m, 2 H, 2-H, 4-H), 4.70
(dd, J = 5.2, 7.0 Hz, 1 H, 3-H), 7.79 (s, 1 H, 5′-H) ppm; 13C NMR
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CH2), 44.8 (t, CH2), 49.4 (d, C-5), 61.6 (t, 2-CH2), 62.3 (t, 5-CH2), 70.3
(d, C-3), 72.0 (t, C-2), 73.1 (t, C-4), 77.5 (s, C-6), 123.8 (d, C-5′), 147.4
(s, C-4′) ppm; IR (ATR): ν˜ = 3310 (OH), 2960–2850 (C-H), 1440, 1370
(C=C), 1050 (C-O-C) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C14H24ClN3NaO4: 356.1342; found 356.1353; C14H24ClN3O4 (333.8):
calcd. C 50.37, H 7.25, N 12.59; found C 49.92, H 6.97, N 12.12.
Divalent Bis-1,2,3-triazole 11: According to GP1, 3-azidopyran 2
(100 mg, 0.432 mmol), TBTA (45.9 mg, 0.086 mmol), CuI (16.5 mg,
0.086 mmol), NEt3 (12 μL, 0.087 mmol) and 1,4-diethynylbenzene
(7) (24.8 mg, 0.197 mmol) were dissolved in MeCN (20 mL). The
orange colored mixture was stirred at r.t. for 24 h and worked up.
The crude product was purified by flash column chromatography
(silica gel, CH2Cl2, CH2Cl2/MeOH, 95:5 then 90:1) affording 11
(74 mg, 64 %) as a yellow solid. M. p. 131 °C; [α]D22 = +0.41 (c = 0.5,
MeOH); 1H NMR (500 MHz, CD3OD): δ = 1.33, 1.41 (2 s, 6 H each,
Me), 2.10 (dt, J ≈ 6.2, 12.2 Hz, 2 H, 5-H), 3.08, 3.14 (AB part of ABX
system, JAB = 11.4 Hz, JAX = 5.1 Hz, JBX = 7.3 Hz, 2 H each, 2-CH2),
3.72 (dd, J = 6.3, 11.3 Hz, 2 H, 5-CH2), 3.93 (dd, J = 6.1, 11.3 Hz, 2
H, 5-CH2), 4.33 (mc, 2 H, 2-H), 4.41 (dd, J = 7.1, 12.0 Hz, 2 H, 4-H),
4.80 (dd, J = 5.3, 7.1 Hz, 2 H, 3-H), 7.94 (s, 4 H, Ar), 8.36 (s, 2 H,
5′-H) ppm; 13C NMR (125 MHz, CD3OD): δ = 22.2, 25.4 (2 q, Me),
48.4 (d, C-5), 60.4 (t, 2-CH2), 61.0 (t, 5-CH2), 69.3 (d, C-3), 70.6
(d, C-2), 71.8 (d, C-4), 76.3 (s, C-6), 122.8 (d, C-5′), 127.3 (d, Ar), 131.6
(s, Ar), 148.0 (s, C-4′) ppm; IR (ATR): ν˜ = 3335 (OH), 2930 (C-H), 1620
(C=C), 1230–1030 (C-O-C) cm–1; HRMS (ESI-TOF): m/z [M + H]+ calcd.
for C28H41N6O8: 589.2980; found 589.2972; [M + Na]+ C28H40N6NaO8:
611.2800; found 611.2797.
Divalent Bis-1,2,3-triazole 12: According to GP1, 3-azidopyran 2
(181 mg, 0.783 mmol), TBTA (83.1 mg, 0.157 mmol), CuI (29.8 mg,
0.157 mmol), NEt3 (21.8 μL, 0.157 mmol) and 1,3-diethynylbenzene
(8) (42.8 mg, 54.1 μL, 0.339 mmol) were dissolved in MeCN (30 mL).
The fluorescent yellow mixture was stirred at r.t. for 48 h and
worked up. The crude product was purified by flash column chro-
matography (silica gel, CH2Cl2, CH2Cl2/MeOH, 95:5 then 90:1) afford-
ing 12 (105 mg, 53 %) as a colorless solid. In addition, the corre-
sponding monosubstituted product was also isolated (7 mg, 4 %)
as a colorless solid. M. p. 171 °C; [α]D22 = +0.34 (c = 0.5, MeOH);
1H NMR (500 MHz, CD3OD): δ = 1.33, 1.41 (2 s, 6 H each, Me), 2.11
(td, J = 6.3, 12.0 Hz, 2 H, 5-H), 3.08, 3.15 (AB part of ABX system,
JAB = 11.4 Hz, JAX = 5.0 Hz, JBX = 7.4 Hz, 2 H each, 2-CH2), 3.72 (dd,
J = 6.3, 11.3 Hz, 2 H, 5-CH2), 3.93 (dd, J = 6.3, 11.3 Hz, 2 H, 5-CH2),
4.33 (dt, J ≈ 5.1, 7.2 Hz, 2 H, 2-H), 4.41 (dd, J = 7.2, 12.0 Hz, 2 H,
4-H), 4.81 (dd, J = 5.3, 7.1 Hz, 2 H, 3-H), 7.52 (t, J = 7.8 Hz, 1 H, Ar),
7.85 (d, J = 7.8 Hz, 2 H, Ar), 8.32 (sb, 1 H, Ar), 8.40 (s, 2 H, 5′-H) ppm;
13C NMR (125 MHz, CD3OD): δ = 23.5, 26.7 (2 q, Me), 49.7 (d, C-5),
61.7 (t, 2-CH2), 62.3 (t, 5-CH2), 70.6 (d, C-3), 71.9 (d, C-2), 73.1 (d,
C-4), 77.6 (s, C-6), 123.0 (d, C-5′), 124.0, 126.4, 130.7 (3 d, Ar), 132.4
(s, Ar), 148.1 (s, C-4′) ppm; IR (ATR): ν˜ = 3285 (OH), 2970–2925
(C-H), 1620 (C=C), 1230–1030 (C-O-C) cm–1; HRMS (ESI-TOF): m/z
[M + Na]+ calcd. for C28H40N6NaO8: 611.2800; found 611.2777.
Divalent Bis-1,2,3-triazole 13: According to GP1, 3-azidopyran 2
(100 mg, 0.432 mmol), TBTA (46.2 mg, 0.087 mmol), CuI (16.6 mg,
0.087 mmol), NEt3 (12 μL, 0.087 mmol) and 1,6-heptadiyne (9)
(18.4 mg, 22.9 μL, 0.198 mmol) were dissolved in MeCN (20 mL).
The mixture was stirred at r.t. for 24 h and worked up. The crude
product was purified by flash column chromatography (silica gel,
CH2Cl2, CH2Cl2/MeOH, 95:5 then 90:1) affording 13 (71 mg, 65 %)
as a colorless solid. In addition, the corresponding monosubstituted
product was also isolated (9 mg, 8 %) as a colorless solid. M. p.
91 °C; [α]D22 = +0.19 (c = 0.5, MeOH); 1H NMR (500 MHz, CD3OD):
δ = 1.29, 1.39 (2 s, 6 H each, Me), 2.05 (m, 4 H, 5-H, CH2), 2.77 (t,
J = 7.5 Hz, 4 H, CH2), 2.95, 3.05 (AB part of ABX system, JAB = 11.4 Hz,
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JAX = 4.7 Hz, JBX = 7.5 Hz, 2 H each, 2-CH2), 3.69 (dd, J = 6.5, 11.3 Hz,
2 H, 5-CH2), 3.89 (dd, J = 6.0, 11.3 Hz, 2 H, 5-CH2), 4.23–4.32 (m, 4
H, 2-H, 4-H), 4.67–4.70 (m, 2 H, 3-H), 7.78 (s, 2 H, 5′-H) ppm; 13C
NMR (125 MHz, CD3OD): δ = 22.0 (q, Me), 24.3 (t, CH2), 25.4 (q, Me),
28.9 (t, CH2), 48.4 (d, C-5), 60.3 (t, 2-CH2), 61.0 (t, 5-CH2), 68.9
(d, C-3), 70.7 (d, C-2), 71.8 (d, C-4), 76.2 (s, C-6), 122.4 (d, C-5′), 146.9
(s, C-4′) ppm; IR (ATR): ν˜ = 3365 (OH), 2970–2925 (C-H), 1450 (C=C),
1230–1030 (C-O-C) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C25H42N6NaO8: 577.2956; found 577.2954.
Divalent Bis-1,2,3-triazole 14: According to GP3, to a solution of
3-azidopyran 2 (70 mg, 0.303 mmol) in 1,4-dioxane (0.8 mL) were
added Cu/C (28 mg, 13 μmol), NEt3 (50 μL, 0.37 mmol) and 1,8-
nonadiyne (10) (14.2 mg, 19.8 μL, 0.132 mmol). The reaction mix-
ture was stirred at 60 °C for 24 h. Additional Cu/C (28 mg, 13 μmol)
and NEt3 (50 μL, 0.37 mmol) were added and the reaction was
stirred at 60 °C for another 24 h. The mixture was filtered through
a pad of Celite® and washed with MeOH. The solvents were re-
moved in vacuo and the crude product was purified by flash col-
umn chromatography (silica gel, CH2Cl2/MeOH, 9:1 to 4:1) affording
14 (71 mg, 91 %) as a pale yellow oil. [α]D22 = +25.9 (c = 1.28, MeOH);
1H NMR (700 MHz, CD3OD): δ = 1.28, 1.39 (2 s, 6 H each, Me), 1.43
(dd, J = 7.9, 15.3 Hz, 4 H, CH2), 1.68–1.75 (m, 4 H, CH2), 2.05 (td,
J ≈ 6.2, 12.2 Hz, 2 H, 5-H), 2.71 (t, J = 7.5 Hz, 4 H, CH2), 2.93, 3.04
(AB part of ABX system, JAB = 11.5 Hz, JAX = 4.7 Hz, JBX = 7.5 Hz,
2 H each, 2-CH2), 3.70 (dd, J = 6.3, 11.4 Hz, 2 H, 5-CH2), 3.89
(dd, J = 6.0, 11.4 Hz, 2 H, 5-CH2), 4.24–4.32 (m, 4 H, 2-H, 4-H), 4.69
(dd, J = 5.2, 6.9 Hz, 2 H, 3-H), 7.73 (s, 2 H, 5′-H) ppm; 13C NMR
(175 MHz, CD3OD): δ = 23.5 (q, Me), 26.1 (t, CH2), 26.7 (q, Me),
29.5, 30.2 (2 t, CH2), 49.6 (d, C-5), 61.6 (t, 2-CH2), 62.3 (t, 5-CH2), 70.2
(d, C-3), 72.0 (d, C-2), 73.1 (d, C-4), 77.5 (s, C-6), 123.4 (d, C-5′), 148.8
(s, C-4′) ppm; IR (ATR): ν˜ = 3450 (OH), 2980–2855 (C-H), 1645 (C=C),
1225–1030 (C-O-C) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C27H46N6NaO8: 605.3269; found 605.3270.
Divalent Tetrakis-1,2,3-triazole 16: According to GP3, to a solu-
tion of 3-azidopyran 2 (31 mg, 0.133 mmol) in 1,4-dioxane (1 mL)
were added Cu/C (23 mg, 10.6 μmol), NEt3 (20 μL, 0.133 mmol) and
diyne 15[13] (25 mg, 53 μmol). The reaction mixture was stirred at
60 °C for 72 h. The mixture was filtered through a pad of Celite®
and washed with MeOH. The solvents were removed in vacuo and
the crude product was purified by flash column chromatography
(silica gel, CH2Cl2/MeOH, 9:1 to 4:1) affording 16 (12 mg, 24 %) as
a yellow solid. M. p. 235 °C; [α]D22 = –20.3 (c = 0.09, MeOH); 1H NMR
(700 MHz, CD3OD): δ = 0.54, 1.27 (2 s, 3 H each, MeA), 1.29, 1.39 (2
s, 6 H each, MeB), 1.93 (mc, 1 H, 6-HA), 2.02–2.10 (m, 6 H, CH2, 5-HB),
2.75–2.78 (m, 8 H, CH2), 2.93–2.98, 3.03–3.06 (2 m, 2 H each,
2-CH2B), 3.54–3.61 (m, 2 H, 6-CH2A), 3.70 (dd, J = 6.4, 11.3 Hz, 2 H,
5-CH2B), 3.89 (dd, J = 6.1, 11.3 Hz, 2 H, 5-CH2B), 4.23–4.28 (m, 2 H,
4-HB, 2-HB), 4.28–4.32 (m, 2 H, 5-HA, 3-HA), 4.43–4.46 (m, 2 H,
2-CH2A, 3-HA), 4.52 (B part of ABX system, JAB = 14.3 Hz, JBX = 3.1 Hz,
1 H, 2-CH2A), 4.60 (dd, J = 7.4, 9.5 Hz, 1 H, 4-HA), 4.68–4.72 (m, 2 H,
3-HB), 7.77 (s, 1 H, 5′-H), 7.77 (sb, 2 H, 5′-H), 7.79 (s, 1 H, 5′-H) ppm;
13C NMR (125 MHz, CD3OD): δ = 20.1, 23.5 (2 q, Me), 25.47, 25.51,
25.52, 25.6 (4 t, CH2), 26.7, 26.8 (2 q, Me), 30.1, 30.5 (2 t, CH2), 30.9,
31.4 (2 q, Me), 49.4 (d, C-5B), 53.2 (t, 2-CH2A), 53.3 (d, C-2A), 60.3 (d,
C-6A), 61.7 (t, 2-CH2B), 62.3 (t, 5-CH2B), 63.5 (t, 6-CH2A), 69.8 (d,
C-3B), 70.3 (d, C-2B), 72.0 (d, C-4B), 73.0 (d, C-5A), 74.3 (d, C-3A), 75.1
(d, C-4A), 77.5, 77.9 (2 s, C-6B, C-7A), 123.65, 123.73, 125.3, 125.4 (4
d, C-5′), 148.21, 148.28, 148.29, 148.31 (4 s, C-4′) ppm;* a specific
assignment of the signals to one of the two pyran rings and to the
four triazole units is not possible. IR (ATR): ν˜ = 3370 (OH), 2925
(C-H), 1595 (C=C), 1060 (C-O-C) cm–1; HRMS (ESI-TOF): m/z
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(2S,3R,4S,5S)-[4-Hydroxy-6,6-dimethyl-3-(4′-methyl-1H-1′,2′,3′-
triazol-1′-yl)tetrahydro-2H-pyran-2,5-diyl]dimethanol (18): Ac-
cording to GP5, to a cooled solution of 3-aminopyran 1 (58 mg,
0.28 mmol) in EtOH (3.3 mL) was added KOAc (83 mg, 0.85 mmol)
and the resulting solution was stirred for 10 min at 0 °C. Tosyl-
hydrazone 17[15] (109 mg, 0.37 mmol) was dissolved in MeCN
(2.2 mL) and added dropwise to the reaction mixture. Stirring was
continued at r.t. for 21 h. All volatiles were removed in vacuo and
the crude product was purified by flash column chromatography
(silica gel, CH2Cl2/MeOH, 9:1) affording 18 (78 mg, quant.) as a col-
orless solid. M. p. 176 °C; [α]D22 = +2.68 (c = 0.77, MeOH); 1H NMR
(500 MHz, CD3OD): δ = 1.28, 1.39 (2 s, 3 H each, Me), 2.05 (td, J ≈
6.2, 12.3 Hz, 1 H, 5-H), 2.33 (s, 3 H, Me), 2.95, 3.05 (AB part of ABX
system, JAB = 11.5 Hz, JAX = 4.8 Hz, JBX = 7.5 Hz, 1 H each, 2-CH2),
3.69 (dd, J = 6.4, 11.3 Hz, 1 H, 5-CH2), 3.89 (dd, J = 6.0, 11.3 Hz, 1
H, 5-CH2), 4.22–4.28 (m, 2 H, 2-H, 4-H), 4.67 (dd, J = 5.1, 7.0 Hz, 1 H,
3-H), 7.72 (s, 1 H, 5′-H) ppm; 13C NMR (125 MHz, CD3OD): δ = 10.5,
23.5, 26.7 (3 q, Me), 49.6 (d, C-5), 61.6 (t, 2-CH2), 62.3 (t, 5-CH2), 70.2
(d, C-3), 71.9 (d, C-2), 73.1 (d, C-4), 77.5 (s, C-6), 123.8 (d, C-5′), 143.9
(s, C-4′) ppm; IR (ATR): ν˜ = 3370 (OH), 3150 (=C-H), 2975–2885
(C-H), 1560, 1440, 1390 (C=C), 1055 (C-O-C) cm–1; HRMS (ESI-TOF):
[M + H]+ calcd. for C12H22N3O4: 272.1605; found 272.1604; [M + Na]+
calcd. for C12H21N3NaO4: 294.1424; found 294.1435; C12H21N3O4




anol (20): According to GP5, to a cooled solution of 3-aminopyran
1 (26 mg, 0.13 mmol) in EtOH (1.5 mL) was added KOAc (37 mg,
0.38 mmol) and the resulting solution was stirred for 10 min at 0 °C.
Tosylhydrazone 19[15] (60 mg, 0.16 mmol) was dissolved in MeCN
(1.2 mL) and added dropwise to the reaction mixture. Stirring was
continued at r.t. for 26 h. All volatiles were removed in vacuo and
the crude product was purified by flash column chromatography
(silica gel, CH2Cl2/MeOH, 95:5 then 9:1) affording 20 (28 mg, 65 %)
as a yellow oil. [α]D22 = +27.3 (c = 1.29, MeOH); 1H NMR (700 MHz,
CD3OD): δ = 1.29, 1.39 (2 s, 3 H each, Me), 1.40–1.45 (m, 2 H, CH2),
1.54–1.60 (m, 2 H, CH2), 1.71 (quint, J = 7.6 Hz, 2 H, CH2), 2.05 (td,
J ≈ 6.2, 12.2 Hz, 1 H, 5-H), 2.73 (t, J = 7.6 Hz, 2 H, CH2), 2.93, 3.04
(AB part of ABX system, JAB = 11.5 Hz, JAX = 4.8 Hz, JBX = 7.6 Hz,
1 H each, 2-CH2), 3.55 (t, J = 6.5 Hz, 2 H, CH2), 3.69 (dd, J = 6.4,
11.3 Hz, 1 H, 5-CH2), 3.89 (dd, J = 6.0, 11.3 Hz, 1 H, 5-CH2), 4.23–
4.31 (m, 2 H, 2-H, 4-H), 4.69 (dd, J = 5.1, 7.0 Hz, 1 H, 3-H), 7.74 (s, 1
H, 5′-H) ppm; 13C NMR (175 MHz, CD3OD): δ = 23.5 (q, Me), 26.3,
26.4 (2 t, CH2), 26.7 (q, Me), 30.4, 33.3 (2 t, CH2), 48.5 (d, C-5), 61.6
(t, 2-CH2), 62.3 (t, 5-CH2), 62.8 (t, CH2), 70.2 (d, C-3), 72.0 (d, C-2),
73.1 (d, C-4), 77.5 (s, C-6), 123.4 (d, C-5′), 148.8 (s, C-4′) ppm; IR
(ATR): ν˜ = 3355 (OH), 2930–2860 (C-H), 1550 (C=C), 1170–1010
(C-O -C ) cm–1 ; HRMS (ES I -TOF) : m /z [M + Na]+ ca l cd . fo r
C16H29N3NaO5: 366.1994; found 366.2001.
Divalent Bis-1,2,3-triazole 22: According to GP5, to a cooled solu-
tion of 3-aminopyran 1 (100 mg, 0.487 mmol) in EtOH (5.7 mL) was
added KOAc (147 mg, 1.49 mmol) and the resulting solution was
stirred for 10 min at 0 °C. Tosylhydrazone 21 [ 25 ] (116 mg,
0.187 mmol) was dissolved in MeCN (3.8 mL) and added dropwise
to the colorless solution. The reaction mixture turned bright yellow
after 10 min. Stirring was continued at r.t. for 20 h. All volatiles
were removed in vacuo and the crude product was purified by
flash column chromatography (silica gel, CH2Cl2/MeOH, 9:1 to 6:1)
affording 22 (80 mg, 75 %) as a colorless solid. M. p. 184 °C; [α]D22 =
+33.2 (c = 1.18, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.29, 1.39
(2 s, 6 H each, Me), 1.69–1.76 (m, 4 H, CH2), 2.05 (td, J ≈ 6.2, 12.2 Hz,
2 H, 5-H), 2.75 (t, J = 6.4 Hz, 4 H, CH2), 2.92, 3.03 (AB part of ABX
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system, JAB = 11.4 Hz, JAX = 4.7 Hz, JBX = 7.5 Hz, 2 H each, 2-CH2),
3.67–3.72 (m, 2 H, 5-CH2), 3.89 (dd, J = 6.0, 11.3 Hz, 2 H, 5-CH2),
4.23–4.30 (m, 4 H, 2-H, 4-H), 4.68 (dd, J = 5.2, 7.0 Hz, 2 H, 3-H), 7.74
(s, 2 H, 5′-H) ppm; 13C NMR (175 MHz, CD3OD): δ = 23.5 (q, Me),
25.9 (t, CH2), 26.7 (q, Me), 29.9 (t, CH2), 49.6 (d, C-5), 61.6 (t, 2-CH2),
62.3 (t, 5-CH2), 70.2 (d, C-3), 72.0 (d, C-2), 73.0 (d, C-4), 77.5 (s, C-6),
123.5 (d, C-5′), 148.6 (s, C-4′) ppm; IR (ATR): ν˜ = 3370 (OH), 2930
(C-H), 1680 (C=C), 1045 (C-O-C) cm–1; HRMS (ESI-TOF): m/z [M + H]+
calcd. for C26H45N6O8: 569.3293; found 569.3301; [M + Na]+ calcd.
for C26H44N6NaO8: 591.3107; found 591.3128.
O-Sulfated Azidopyran 23: According to GP6, 3-azidopyran 2
(19 mg, 0.082 mmol), SO3-DMF (47 %, 240 mg, 0.739 mmol) and
[D7]DMF (0.8 mL) were stirred overnight. After 1H-NMR spectro-
scopic control, the reaction mixture was stirred for 2 d and each
day a new portion of SO3-DMF (120 mg) was added. According to
method G/a, 1 M NaOH solution was added dropwise until pH 12
was reached. The solvents were removed in vacuo and the crude
product was purified by dialysis (tube width: 10–16 mm, molecular
weight cut off: 100–500 Da). The product was filtered through a
syringe filter affording 23 (5 mg, 11 %) as a colorless solid. M. p.
203 °C (decomposition); [α]D22 = +13.5 (c = 0.08, H2O); 1H NMR
(700 MHz, D2O): δ = 1.28, 1.50 (2 s, 3 H each, Me), 2.41 (dt, J = 4.4,
7.9 Hz, 1 H, 5-H), 4.03–4.06 (m, 1 H, 3-H), 4.11 (dd, J = 7.4, 10.7 Hz,
1 H, 2-CH2), 4.23 (dd, J = 4.9, 10.7 Hz, 1 H, 2-CH2), 4.30 (d, J = 7.9 Hz,
2 H, 5-CH2), 4.46 (ddd, J = 2.5, 4.9, 7.4 Hz, 1 H, 2-H), 4.86–4.87 (m,
1 H, 4-H) ppm; 13C NMR (175 MHz, D2O): δ = 25.6, 25.7 (2 q, Me),
42.6 (d, C-5), 59.7 (d, C-3), 66.5 (d, C-2), 66.7 (t, 5-CH2), 67.6 (t,
2-CH2), 74.2 (d, C-4), 75.3 (s, C-6) ppm; IR (ATR): ν˜ = 2905 (C-H), 2110
(N3), 1240 (C-O), 1130 (C-O-C, SO3Na) cm–1; HRMS (ESI-TOF): m/z
[M + Na]+ calcd. for C9H14N3Na4O13S3: 559.9274; found 559.9418.
O-Sulfated 1,2,3-Triazole Derivative 24: According to GP6, 1,2,3-
tr iazole 18 (13 mg, 0 .048 mmol) , SO3-DMF (97 %, 66 mg,
0.431 mmol) and [D7]DMF (0.8 mL) were stirred overnight. After 1H-
NMR spectroscopic control, the reaction mixture was stirred for 4 d
and each day a new portion of SO3-DMF (66 mg) was added. Ac-
cording to method G/b, 0.5 M NaOH solution was added dropwise
until pH 8 was reached. The reaction mixture was filtered through
an ion exchange DOWEX® Na+ column. The solvents were removed
in vacuo and the crude product was purified by dialysis (tube width:
10–16 mm, molecular weight cut off: 100–500 Da). The product was
filtered through a syringe filter affording 24 (4 mg, 14 %) as a color-
less solid. M. p. 246 °C (decomposition); 1H NMR (700 MHz, D2O):
δ = 1.45, 1.50, 2.34 (3 s, 3 H each, Me), 2.67–2.73 (m, 1 H, 5-H), 3.53
(dd, J = 7.4, 10.7 Hz, 1 H, 2-CH2), 3.57–3.61 (m, 1 H, 2-CH2), 4.14–
4.25 (m, 1 H, 5-CH2), 4.38 (dd, J = 4.6, 10.7 Hz, 1 H, 5-CH2), 4.75 (m,
1 H, 2-H), 4.93–4.96 (m, 1 H, 4-H), 5.07–5.17 (m, 1 H, 3-H), 7.83 (s, 1
H, 5′-H) ppm; 13C NMR (175 MHz, D2O): δ = 9.6, 22.2, 26.0 (3 q, Me),
44.0 (d, C-5), 65.4 (d, C-3), 65.7 (t, 2-CH2), 66.5 (t, 5-CH2), 67.9 (d,
C-2), 77.9 (d, C-4), 77.3 (s, C-6), 125.5 (d, C-5′)* ppm; *C-5′ attributed
by HMQC; the signal of C-4′ could not be detected unambiguously;
IR (ATR): ν˜ = 1640 (C=C), 1225 (C-O), 1130 (C-O-C, SO3Na) cm–1;
HRMS (ESI-TOF): m/z [M + Na]+ calcd. for C12H18N3Na4O13S3:
599.9587; found 599.9661.
O-Sulfated Divalent Bis-1,2,3-triazole 25: According to GP6, bis-
1,2,3-triazole 13 (15 mg, 0.027 mmol), SO3-DMF (97 %, 75 mg,
0.49 mmol) and [D7]DMF (0.6 mL) were stirred overnight. After
1H-NMR spectroscopic control, the reaction mixture was stirred for
1 d and each day a new portion of SO3-DMF (60 mg) was added.
According to method G/a, 1 M NaOH solution was added dropwise
until pH 12 was reached. The solvents were removed in vacuo and
the crude product was purified by dialysis (tube width: 10–16 mm,
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through a syringe filter affording 25 (15 mg, 48 %) as a colorless
solid. M. p. 267 °C (decomposition); [α]D22 = +65.2 (c = 0.1, H2O); 1H
NMR (700 MHz, D2O): δ = 1.46, 1.51 (2 s, 6 H each, Me), 2.04–2.12
(m, 2 H, CH2), 2.66–2.74 (m, 2 H, 5-H), 2.78 (t, J = 6.7 Hz, 4 H, CH2),
3.51 (dd, J = 7.7, 11.0 Hz, 2 H, 2-CH2), 3.65 (dd, J = 4.8, 11.0 Hz,
2 H, 2-CH2), 4.20 (mc, 2 H, 5-CH2), 4.41 (dd, J = 4.4, 10.8 Hz, 2 H,
5-CH2), 4.74–4.77 (m, 2 H, 2-H), 4.97 (dd, J = 6.5, 12.1 Hz, 2 H, 4-H),
5.16 (mc, 2 H, 3-H), 7.92 (s, 2 H, 5′-H) ppm; 13C NMR (175 MHz, D2O):
δ = 22.2 (q, Me), 23.7 (t, CH2), 26.0 (q, Me), 28.0 (t, CH2), 44.1
(d, C-5), 65.6 (d, C-3), 65.8 (t, 2-CH2), 66.6 (t, 5-CH2), 68.1 (d, C-2),
77.3 (d, C-4), 77.9 (s, C-6), 124.5 (d, C-5′), 151.2 (s, C-4′) ppm; IR
(ATR): ν˜ = 2950–2850 (C-H), 1640 (C=C), 1220 (C-O), 1130 (C-O-C,
SO3Na ) cm–1 ; HRMS (ES I -TOF ) : m / z [M + Na ] + ca l cd . fo r
C25H36N6Na7O26S6: 1188.9281; found 1188.9303.
O-Sulfated Divalent Bis-1,2,3-triazole 26: According to GP6, bis-
1,2,3-triazole 22 (30 mg, 0.053 mmol), SO3-DMF (97 %, 145 mg,
0.949 mmol) and [D7]DMF (0.8 mL) were stirred overnight. After 1H-
NMR spectroscopic control, the reaction mixture was stirred for 3 d
and each day a new portion of SO3-DMF (145 mg) was added. Ac-
cording to method G/b, 0.5 M NaOH solution was added dropwise
until pH 8 was reached. The reaction mixture was filtered through
an ion exchange DOWEX® Na+ column. The solvents were removed
in vacuo and the crude product was purified by dialysis (tube width:
10–16 mm, molecular weight cut off: 100–500 Da). The product was
filtered through a syringe filter affording 26 (54 mg, 87 %) as a
colorless solid. M. p. 269 °C (decomposition); [α]D22 = +25.1 (c = 0.06,
H2O); 1H NMR (700 MHz, D2O): δ = 1.47, 1.52 (2 s, 6 H each, Me),
1.73 (sb, 4 H, CH2), 2.68–2.76 (m, 2 H, 5-H), 2.79 (sb, 4 H, CH2), 3.51
(dd, J = 7.7, 10.8 Hz, 2 H, 2-CH2), 3.65 (dd, J = 4.8, 10.8 Hz, 2 H,
2-CH2), 4.21 (mc, 2 H, 5-CH2), 4.41 (dd, J = 4.6, 10.9 Hz, 2 H, 5-CH2),
4.75–4.77 (m, 2 H, 2-H), 4.99 (dd, J = 6.3, 12.1 Hz, 2 H, 4-H), 5.14–
5.19 (m, 2 H, 3-H), 7.90 (s, 2 H, 5′-H) ppm; 13C NMR (175 MHz, D2O):
δ = 22.3 (q, Me), 24.1 (t, CH2), 26.0 (q, Me), 27.9 (t, CH2), 44.1 (d,
C-5), 65.4 (d, C-3), 65.5 (t, 2-CH2), 66.6 (t, 5-CH2), 68.1 (d, C-2), 77.2
(d, C-4), 77.9 (s, C-6), 124.3 (d, C-5′), 148.7 (s, C-4′) ppm; IR (ATR): ν˜ =
2970–2850 (C-H), 1440 (C=C), 1225 (C-O), 1200 (SO3Na) cm–1; HRMS
(ESI-TOF): m/z [M + Na]+ calcd. for C26H38N6Na7O26S6: 1202.9438;
found 1202.9407.
O-Sulfated Divalent Bis-1,2,3-triazole 27: According to GP6, bis-
1,2,3-triazole 14 (15 mg, 0.026 mmol), SO3-DMF (47 %, 151 mg,
0.463 mmol) and [D7]DMF (0.7 mL) were stirred overnight. After 1H-
NMR spectroscopic control, the reaction mixture was stirred for 1 d
and each day a new portion of SO3-DMF (151 mg) was added. Ac-
cording to method G/a, 1 M NaOH solution was added dropwise
until pH 12 was reached. The solvents were removed in vacuo and
the crude product was purified twice by dialysis (tube width: 10–
16 mm, molecular weight cut off: 100–500 Da). The product was
filtered through a syringe filter affording 32 (12 mg, 39 %) as a
colorless solid. M. p. 265 °C (decomposition); [α]D22 = +30.5 (c = 0.08,
H2O); 1H NMR (700 MHz, D2O): δ = 1.40, 1.47 (2 s, 6 H each, Me),
1.63–1.76 (m, 4 H, CH2), 2.62–2.67 (m, 2 H, 5-H), 2.67–2.70 (m, 6 H,
CH2), 3.41–3.51 (m, 2 H, 2-CH2), 3.59 (B part of ABX system, JAB =
10.8 Hz, JBX = 4.9 Hz, 2 H, 2-CH2), 4.11–4.22 (m, 2 H, 5-CH2), 4.36
(dd, J = 4.5, 10.7 Hz, 2 H, 5-CH2), 4.67–4.73 (m, 2 H, 2-H), 4.93 (dd,
J = 6.6, 12.1 Hz, 2 H, 4-H), 5.07–5.14 (m, 2 H, 3-H), 7.84 (s, 2 H,
5′-H) ppm; 13C NMR (175 MHz, D2O): δ = 22.2 (q, Me), 24.4 (t, CH2),
26.0 (q, Me), 27.7, 28.3 (2 t, CH2), 44.1 (d, C-5), 65.5 (d, C-3), 65.7 (t,
2-CH2), 66.6 (t, 5-CH2), 68.1 (d, C-2), 77.2 (d, C-4), 77.9 (s, C-6), 124.0
(d, C-5′)* ppm; *C-5′ attributed by HMQC; the signal of C-4′ could
not be detected unambiguously; IR (ATR): ν˜ = 2910 (C-H), 1460
(C=C), 1205 (SO3Na) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C27H40N6Na7O26S6: 1216.9600; found 1216.9607.
Eur. J. Org. Chem. 2020, 4361–4370 www.eurjoc.org © 2020 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim4369
SPR measurements: Experiments were performed on a BIACORE X
instrument (GE Healthcare, Freiburg, Germany) at 25 °C using a sen-
sor chip (sensor chip SA, GE Healthcare). For further details see
Supporting Information.
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